Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016–2018)
- 21 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 59 (5) , 422-430
Abstract
Systematic candidemia studies, especially in southern Iran, are scarce. In the current prospective study, we investigated candidemia in three major healthcare centers of Shiraz, the largest city in southern Iran. Yeast isolates from blood and other sterile body fluids were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and subjected to antifungal susceptibility testing (AFST) using the broth microdilution method. Clinical data were retrieved from patients’ medical records. In total, 113 yeast isolates were recovered from 109 patients, over 60% of whom received fluconazole. Antifungal drugs were prescribed without considering species identification or AFST. The all-cause mortality rate was 28%. Almost 30% of the patients were from intensive care units (ICUs). Candida albicans (56/113; 49.5%) was the most prevalent species followed by C. glabrata (26/113; 23%), C. parapsilosis (13/113; 11.5%), C. tropicalis (7/113; 6.2%), and C. dubliniensis (5/113; 4.4%). Only five isolates showed antifungal resistance or decreased susceptibility to fluconazole: one C. orthopsilosis isolate from an azole-naïve patient and two C. glabrata, one C. albicans, and one C. dubliniensis isolates from patients treated with azoles, who developed therapeutic failure against azoles later. Our results revealed a low level of antifungal resistance but a notable rate of azole therapeutic failure among patients with candidemia due to non-albicans Candida species, which threaten the efficacy of fluconazole, the most widely used antifungal in southern regions of Iran. Candidemia studies should not be confined to ICUs and treatment should be administered based on species identification and AFST results.Keywords
Funding Information
- Shiraz University of Medical Sciences (97-01-106-19371)
This publication has 40 references indexed in Scilit:
- One fungus, which genes? Development and assessment of universal primers for potential secondary fungal DNA barcodesPersoonia - Molecular Phylogeny and Evolution of Fungi, 2015
- Twenty-two years of candidaemia surveillance: results from a Norwegian national studyClinical Microbiology and Infection, 2015
- Changing epidemiology of candidemia in a medical center in middle TaiwanJournal of Microbiology, Immunology and Infection, 2015
- Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal UsagePLOS ONE, 2015
- Incidence, characteristics and outcome of ICU-acquired candidemia in IndiaIntensive Care Medicine, 2014
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?Antimicrobial Agents and Chemotherapy, 2013
- Hidden Killers: Human Fungal InfectionsScience Translational Medicine, 2012
- Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011Journal of Clinical Microbiology, 2012
- Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012Journal of Clinical Microbiology, 2012
- Antifungal Susceptibility of Bloodstream Candida Isolates in Sfax Hospital: TunisiaMycopathologia, 2010